PTPRC and myeloid sarcoma: We found that CD45+ leukocytes and pro-inflammatory cytokines were present in the CSF of aMCI patients, at levels equivalent to or exceeding those found in early MS patients [17], a prototypical inflammatory CNS disease [51].